R-Pharm Germany

R-Pharm Germany's insolvency administrator said about 280 employees were affected after a failed investor process forced the Illertissen operation to shut down.

A group of 50 to 60 employees will remain temporarily to complete the orderly wind-down. The administrator said sanctions-related ownership uncertainty and declining orders had weakened the business before the investor process failed.